期刊
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY
卷 27, 期 6, 页码 921-930出版社
OXFORD UNIV PRESS
DOI: 10.1093/icvts/ivy282
关键词
Heart failure; Review; Heart failure with reduced ejection fraction; Heart failure with preserved ejection fraction; Heart failure with mid-range ejection fraction; Ejection fraction; Pharmacotherapy; Comorbidities
Even though significant progress has been made over the past 3 decades, heart failure remains one of the leading causes of mortality and morbidity in developed countries and contributes significantly to the economic burden of modern health care systems. Especially in patients with preserved ejection fraction, valid therapeutic options are missing due to a lack of evidence. In face of a very heterogeneous condition with an ongoing debate over aetiology and pathophysiology, clinicians face a challenge in providing optimal care for these patients. Recent data suggest that the optimal treatment of the underlying conditions as well as comorbidities that are associated with heart failure might play an ever increasing role in improving outcomes. This focused review summarizes and reviews current data for the treatment of heart failure with both preserved and reduced ejection fractions based on the latest recommendations covering medical therapy and interventional strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据